Beirne Wealth Consulting Services, LLC Merck & Co., Inc. Transaction History

Beirne Wealth Consulting Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $233,719 - $254,343	2,333 New	2,333 $256 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $249,548 - $293,942	-3,624 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$71.77 - $79.65 $1,220 - $1,354	-17 Reduced 0.47%	3,624 $299,000
Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $266,448 - $302,020	3,641 New	3,641 $304,000
Q2 2019 Jul 25, 2019	SELL	$69.84 - $81.59 $365,821 - $427,368	-5,238 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $14,820 - $16,903	213 Added 4.24%	5,238 $438,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $327,831 - $380,442	5,025 New	5,025 $387,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.